A Biomarker for Brain Injury in Critically Ill Newborns
A study published in *Pediatric Research* investigates the potential of blood lactate kinetics as a non-invasive biomarker for MRI-confirmed brain injury in neonates with encephalopathy. This research focuses on the dynamic changes in lactate levels, a key marker of anaerobic metabolism and tissue hypoxia, and correlates them with neurological outcomes. The findings suggest that tracking how quickly lactate clears from the bloodstream could provide critical, real-time insights into the severity of brain injury, offering a tool that is more accessible and frequent than MRI scans in an intensive care setting.
Why it might matter to you: For critical care professionals managing neonatal encephalopathy, this research points toward a practical biomarker for monitoring disease progression and response to therapy. Integrating lactate clearance kinetics into your hemodynamic and metabolic monitoring protocols could enhance early detection of worsening brain injury, informing decisions on interventions like targeted temperature management or adjustments in cardiorespiratory support. It represents a move toward more dynamic, physiology-driven biomarkers in neonatal intensive care.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
